Chargement en cours...
Enhancement of sialylation in rIgG in glyco-engineered Chinese hamster ovary cells
Since about 70% of commercial biopharmaceutical products have been produced in Chinese hamster ovary (CHO) cells, this cell line is undeniably a workhorse for biopharmaceuticals production. Meanwhile, sialic acid terminals were reported to affect anti-inflammatory activity, antibody-dependent cellul...
Enregistré dans:
| Publié dans: | Cytotechnology |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer Netherlands
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7225233/ https://ncbi.nlm.nih.gov/pubmed/32125558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10616-020-00381-z |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|